Xxera/openscience/retractions

Record #25661

MiR-148a agomir based targeting of c-Met and Her-3 is able to attenuate EGFR-T790M mutation driven gefitinib and erlotinib resistance in non-small cell lung cancer cells

Guimin Chen, Lei Ye, Yufei Han, Ping Han

Journal

Publisher

Royal Society of Chemistry (RSC)

Original paper date

Jul 5, 2019

Original DOI

10.1039/C8RA10224D

Country

Institution

Department II of Internal Medicine, Lin Yi Cancer Hospital, Linyi, Shandong, China · Department I of Internal Medicine, Lin Yi Cancer Hospital, Linyi, Shandong, China · Department II of Respiration, Linyi People's Hospital, No. 6, East Lingyuan Street, Lanshan District, Linyi, Shandong, China

Open access

No

Article type

Research Article

Broad categories

(BLS) Biochemistry (BLS) Biology - Cancer (BLS) Biology - Cellular (BLS) Genetics (HSC) Medicine - Oncology (HSC) Medicine - Pulmonology

Citation lifecycle

How this paper is being cited

Pre-retraction

0

Same day

0

Post-retraction

0

% post-retraction

0.0%

~0.0 citations/yr before retraction · ~0.0 citations/yr after

— citing papers

Who is still citing this work

Loading…